Chemed Corporation (CHE)

NYSE: CHE · IEX Real-Time Price · USD
436.56
-9.54 (-2.14%)
Sep 30, 2022 4:00 PM EDT - Market closed
-2.14%
Market Cap 6.51B
Revenue (ttm) 2.14B
Net Income (ttm) 277.25M
Shares Out 14.90M
EPS (ttm) 17.95
PE Ratio 24.32
Forward PE 22.08
Dividend $1.46 (0.33%)
Ex-Dividend Date Aug 12, 2022
Volume 82,731
Open 443.01
Previous Close 446.10
Day's Range 435.28 - 447.72
52-Week Range 403.00 - 539.87
Beta 0.51
Analysts Buy
Price Target 575.28 (+31.8%)
Earnings Date Oct 26, 2022

About CHE

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in C... [Read more...]

Industry Health Care Providers & Services
CEO Kevin McNamara
Employees 14,137
Stock Exchange NYSE
Ticker Symbol CHE
Full Company Profile

Financial Performance

In 2021, Chemed's revenue was $2.14 billion, an increase of 2.87% compared to the previous year's $2.08 billion. Earnings were $268.55 million, a decrease of -15.94%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for CHE stock is "Buy." The 12-month stock price forecast is 575.28, which is an increase of 31.78% from the latest price.

Price Target
$575.28
(31.78% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Chemed (CHE) Roto-Rooter Business Grows, VITAS Admission Dips

The performance of Chemed's (CHE) VITAS business is somewhat offset by a geographically weighted average Medicare reimbursement rate increase.

3 days ago - Zacks Investment Research

Chemed's (CHE) Roto-Rooter Growth Aids, Macro Challenges Ail

Chemed's (CHE) VITAS segment revenue decline during the second quarter gets somewhat offset by a geographically weighted average Medicare reimbursement rate increase of nearly 1.3%.

4 weeks ago - Zacks Investment Research

Here's Why You Should Hold on to Chemed (CHE) Stock Now

Investors are optimistic about Chemed's (CHE) better-than-expected earnings and impressive Roto-Rooter results.

1 month ago - Zacks Investment Research

PNTG vs. CHE: Which Stock Should Value Investors Buy Now?

PNTG vs. CHE: Which Stock Is the Better Value Option?

Other symbols: PNTG
1 month ago - Zacks Investment Research

5 Stocks in Focus That Recently Hiked Their Dividends

Investors should consider stocks that have recently raised their dividend payments. These are: HRB, CHE, SU, OTEX, ESNT.

Other symbols: ESNTHRBOTEXSU
1 month ago - Zacks Investment Research

Chemed Corporation Declares Quarterly Dividend of 38 Cents

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 38-cents per share on the Company's capital stock, payabl...

1 month ago - Business Wire

Chemed (CHE) Q2 Earnings Surpass Estimates, Margins Grow

Chemed (CHE) reports better-than-expected earnings in the second quarter, with a robust performance by the Roto-Rooter segment driving the top line.

2 months ago - Zacks Investment Research

Chemed (CHE) Q2 Earnings Surpass Estimates

Chemed (CHE) delivered earnings and revenue surprises of 1.26% and 1.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Chemed Reports Second-Quarter 2022 Results

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the...

2 months ago - Business Wire

Here's Why You Should Retain Chemed (CHE) Stock For Now

Investors are optimistic about Chemed (CHE) owing to the robust demand for Roto-Rooter services and the ongoing rebound in senior housing admissions.

2 months ago - Zacks Investment Research

Chemed To Report Second-Quarter 2022 Earnings July 27, Related Conference Call To Be Held On July 28

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2022, on Wednesday, July 27, 2022, following the ...

2 months ago - Business Wire

Chemed Corporation Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Facility

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into $550 million of amended and restated senior secured credit facilities (“Credit Facilities”). JPMo...

3 months ago - Business Wire

Chemed (CHE) Surges 3.3%: Is This an Indication of Further Gains?

Chemed (CHE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

3 months ago - Zacks Investment Research

Here's Why Investors Should Retain Chemed (CHE) Stock Now

Strong performance across Chemed's (CHE) Roto-Rooter arm and increased home-based admissions raise investors' confidence.

3 months ago - Zacks Investment Research

Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2022 Healthcare Conference on Thursday, June 9, 2022, at approximately 8:...

3 months ago - Business Wire

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2022 annual stockholders' meeting. Each of the directors continues from ...

4 months ago - Business Wire

Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022, at appr...

4 months ago - Business Wire

Chemed Corporation to Present at the Bank of America Merrill Lynch 2022 Health Care Conference

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2022 Health Care Conference on Tuesday, May 10, 2022, ...

4 months ago - Business Wire

Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase

In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.

5 months ago - Zacks Investment Research

Chemed (CHE) Q1 Earnings Surpass Estimates

Chemed (CHE) delivered earnings and revenue surprises of 6.68% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Chemed Reports First-Quarter 2022 Results

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the...

5 months ago - Business Wire

Here's Why You Should Hold on to Chemed (CHE) Stock For Now

Investors are optimistic about robust performance by Chemed's (CHE) Roto-Rooter arm.

5 months ago - Zacks Investment Research

Chemed To Report First-Quarter 2022 Earnings April 26, Related Conference Call To Be Held On April 27

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2022, on Tuesday, April 26, 2022, following the c...

5 months ago - Business Wire

Chemed Corporation to Present at the Oppenheimer 32nd Annual Healthcare Conference

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022, ...

6 months ago - Business Wire

Chemed (CHE) Roto-Rooter Sales Robust Despite COVID-19 Woes

Chemed's (CHE) Roto-Rooter business gains from growing demand for plumbing, drain cleaning and excavation and water restoration services.

6 months ago - Zacks Investment Research